Cargando…
Characterization of the cellular transport mechanisms for the anti‐cachexia candidate compound TCMCB07
BACKGROUND: Cachexia is a debilitating, life‐threatening condition whose pathology includes reduced food intake accompanied by hypermetabolism, leading to a catabolic state. The hypothalamic melanocortin system is a critical regulator of metabolic rate with effects being mediated through the melanoc...
Autores principales: | Hu, Yongjun, Gruber, Kenneth A., Smith, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749613/ https://www.ncbi.nlm.nih.gov/pubmed/32725770 http://dx.doi.org/10.1002/jcsm.12602 |
Ejemplares similares
-
Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2023) -
Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2021) -
Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery
por: Pisano, Calogera, et al.
Publicado: (2021) -
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
por: Cortez, Natalia E., et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)